Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2006 1
2008 1
2009 3
2010 1
2011 7
2012 11
2013 13
2014 17
2015 13
2016 12
2017 22
2018 18
2019 19
2020 27
2021 24
2022 25
2023 20
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Results by year

Filters applied: . Clear all
Page 1
Pulmonary alveolar proteinosis.
Jouneau S, Ménard C, Lederlin M. Jouneau S, et al. Respirology. 2020 Aug;25(8):816-826. doi: 10.1111/resp.13831. Epub 2020 May 3. Respirology. 2020. PMID: 32363736 Free article. Review.
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.
Mankikian J, Caille A, Reynaud-Gaubert M, Agier MS, Bermudez J, Bonniaud P, Borie R, Brillet PY, Cadranel J, Court-Fortune I, Crestani B, Debray MP, Gomez E, Gondouin A, Hirschi-Santelmo S, Israel-Biet D, Jouneau S, Juvin K, Leger J, Kerjouan M, Marquette CH, Naccache JM, Nunes H, Plantier L, Prevot G, Quetant S, Traclet J, Valentin V, Uzunhan Y, Wémeau-Stervinou L, Bejan-Angoulvant T, Cottin V, Marchand-Adam S; EVER-ILD investigators and the OrphaLung network. Mankikian J, et al. Among authors: jouneau s. Eur Respir J. 2023 Jun 8;61(6):2202071. doi: 10.1183/13993003.02071-2022. Print 2023 Jun. Eur Respir J. 2023. PMID: 37230499 Free article. Clinical Trial.
Benralizumab for eosinophilic granulomatosis with polyangiitis.
Cottu A, Groh M, Desaintjean C, Marchand-Adam S, Guillevin L, Puechal X, Beaumesnil S, Lazaro E, Samson M, Taille C, Durel CA, Diot E, Nicolas S, Guilleminault L, Ebbo M, Cathebras P, Dupin C, Yildiz H, Belfeki N, Pugnet G, Chauvin P, Jouneau S, Lifermann F, Martellosio JP, Cottin V, Terrier B; French Vasculitis Study Group. Cottu A, et al. Among authors: jouneau s. Ann Rheum Dis. 2023 Dec;82(12):1580-1586. doi: 10.1136/ard-2023-224624. Epub 2023 Aug 7. Ann Rheum Dis. 2023. PMID: 37550002
Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS.
Grégoire M, Uhel F, Lesouhaitier M, Gacouin A, Guirriec M, Mourcin F, Dumontet E, Chalin A, Samson M, Berthelot LL, Tissot A, Kerjouan M, Jouneau S, Le Tulzo Y, Tarte K, Zmijewski JW, Tadié JM. Grégoire M, et al. Among authors: jouneau s. Eur Respir J. 2018 Aug 2;52(2):1702590. doi: 10.1183/13993003.02590-2017. Print 2018 Aug. Eur Respir J. 2018. PMID: 29946009 Free article.
New guidelines for acute COPD exacerbations.
Jouneau S, Chabot F, Roche N. Jouneau S, et al. Rev Mal Respir. 2017 Apr;34(4):279-281. doi: 10.1016/j.rmr.2017.05.001. Rev Mal Respir. 2017. PMID: 28599784 No abstract available.
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israël-Biet D, Prévot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Rivière F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastré J, Le Borgne-Krams A, Dégot T, Launois C, Plantier L, Wémeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H; EXAFIP investigators and the OrphaLung network. Naccache JM, et al. Among authors: jouneau s. Lancet Respir Med. 2022 Jan;10(1):26-34. doi: 10.1016/S2213-2600(21)00354-4. Epub 2021 Sep 7. Lancet Respir Med. 2022. PMID: 34506761 Clinical Trial.
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
Lescoat A, Lelong M, Jeljeli M, Piquet-Pellorce C, Morzadec C, Ballerie A, Jouneau S, Jego P, Vernhet L, Batteux F, Fardel O, Lecureur V. Lescoat A, et al. Among authors: jouneau s. Biochem Pharmacol. 2020 Aug;178:114103. doi: 10.1016/j.bcp.2020.114103. Epub 2020 Jun 17. Biochem Pharmacol. 2020. PMID: 32562787 Free article.
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.
Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, Maurier F, Jouneau S, Bienvenu B, Puéchal X, Aumaître O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogué B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L; French Vasculitis Study Group. Comarmond C, et al. Among authors: jouneau s. Arthritis Rheum. 2013 Jan;65(1):270-81. doi: 10.1002/art.37721. Arthritis Rheum. 2013. PMID: 23044708 Free article.
Outpatient management of primary spontaneous pneumothorax.
Jouneau S, Vuillard C, Salé A, Bazin Y, Sohier L, Kerjouan M, Ricard JD, Messika J. Jouneau S, et al. Respir Med. 2021 Jan;176:106240. doi: 10.1016/j.rmed.2020.106240. Epub 2020 Nov 20. Respir Med. 2021. PMID: 33248364 Free article. Review.
[Idiopathic pulmonary fibrosis: Update of French practical guidelines].
Cottin V, Bonniaud P, Cadranel J, Jouneau S, Marchand-Adam S, Nunes H, Wémeau-Stervinou L, Crestani B. Cottin V, et al. Among authors: jouneau s. Rev Mal Respir. 2022 Mar;39(3):193-198. doi: 10.1016/j.rmr.2022.03.004. Epub 2022 Mar 22. Rev Mal Respir. 2022. PMID: 35337709 French. No abstract available.
206 results